W. Twesten et al., Clinical, endocrine, and molecular genetic findings in patients with 17 beta-hydroxysteroid dehydrogenase deficiency, HORMONE RES, 53(1), 2000, pp. 26-31
Mutations in the 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) type 3
gene are associated with the clinical findings of 17 beta-HSD deficiency. W
e investigated 5 patients of German descent with 46,XY karyotype and predom
inantly female phenotype. Androstenedione (A) and testosterone (T) levels i
n serum were determined before and after stimulation with human chorionic g
onadotropin. DNA analysis of the whole coding region of the 17 beta-HSD typ
e 3 gene was performed by PCR, single-strand conformation analysis, and dir
ect sequencing. In all patients we found highly variable A and T levels bef
ore and after stimulation. However, the A-to-T ratio was abnormal in all ca
ses suggestive of 17 beta-HSD deficiency. Molecular genetic analysis reveal
ed mutations in all patients. We conclude that A and T levels may be highly
variable in patients with 17 beta-HSD deficiency. Molecular genetic analys
is of the 17 beta-HSD gene may support the diagnosis of this disorder. Copy
right (C) 2000 S. Karger AG, Basel.